(Q54483949)

30 May 2018

title

Cetuximab in combination with anti-human IgG antibodies efficiently down-regulates the EGF receptor by macropinocytosis. (English)

1 reference

30 May 2018

1 reference

1 reference

1 reference

2

Inger Helene Madshus

1 reference

30 May 2018

Christian Berger

series ordinal

1

object named as

Christian Berger

1 reference

30 May 2018

author name string

Espen Stang

series ordinal

3

1 reference

30 May 2018

language of work or name

English

0 references

publication date

11 September 2012

1 reference

30 May 2018

Experimental Cell Research

published in

1 reference

30 May 2018

volume

318

1 reference

30 May 2018

issue

20

1 reference

30 May 2018

page(s)

2578-2591

1 reference

30 May 2018

EGFR and cancer prognosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

ERBB receptors and cancer: the complexity of targeted inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

New trends in epidermal growth factor receptor-directed monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cell signaling by receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Clathrin-independent endocytosis: mechanisms and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Mechanisms of endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Defining macropinocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Macropinocytosis: an endocytic pathway for internalising large gulps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cetuximab in combination therapy: from bench to clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cetuximab: from bench to bedside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Nuclear trafficking of the epidermal growth factor receptor family membrane proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Grb2 regulates internalization of EGF receptors through clathrin-coated pits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Activation of the epidermal growth factor (EGF) receptor induces formation of EGF receptor- and Grb2-containing clathrin-coated pits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

On the preparation of cryosections for immunocytochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Clathrin-independent endocytosis of ubiquitinated cargos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Induction of mutant dynamin specifically blocks endocytic coated vesicle formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Nimotuzumab and cetuximab block ligand-independent EGF receptor signaling efficiently at different concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Visualisation of macropinosome maturation by the recruitment of sorting nexins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

The coated pit and macropinocytic pathways serve distinct endosome populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

Association of early endosomal autoantigen 1 with macropinocytosis in EGF-stimulated A431 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.001

10.1016/J.YEXCR.2012.09.001

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018